Safety and Glycemic Outcomes During the MiniMed™ Advanced Hybrid Closed-Loop System Pivotal Trial in Adolescents and Adults with Type 1 Diabetes.
Saved in:
| Title: | Safety and Glycemic Outcomes During the MiniMed™ Advanced Hybrid Closed-Loop System Pivotal Trial in Adolescents and Adults with Type 1 Diabetes. |
|---|---|
| Authors: | Carlson AL; International Diabetes Center, HealthPartners Institute, Minneapolis, Minnesota, USA., Sherr JL; Yale University School of Medicine Pediatric Endocrinology, New Haven, Connecticut, USA., Shulman DI; University of South Florida Diabetes and Endocrinology, Tampa, Florida, USA., Garg SK; Barbara Davis Center of Childhood Diabetes, Aurora, Colorado, USA., Pop-Busui R; Division of Metabolism, Endocrinology and Diabetes, University of Michigan, Ann Arbor, Michigan, USA., Bode BW; Atlanta Diabetes Associates, Atlanta, Georgia, USA., Lilenquist DR; Rocky Mountain Diabetes and Osteoporosis Center, Idaho Falls, Idaho, USA., Brazg RL; Rainier Clinical Research Center, Renton, Washington, USA., Kaiserman KB; SoCal Diabetes, Torrance, California, USA., Kipnes MS; Diabetes and Glandular Disease Clinic, San Antonio, Texas, USA., Thrasher JR; Arkansas Diabetes and Endocrinology Center, Little Rock, Arkansas, USA., Reed JHC; Endocrine Research Solutions, Inc., Roswell, Georgia, USA., Slover RH; Barbara Davis Center of Childhood Diabetes, Aurora, Colorado, USA., Philis-Tsimikas A; Scripps Whittier Diabetes Institute, La Jolla, California, USA., Christiansen M; Diablo Clinical Research Center, Walnut Creek, California, USA., Grosman B; Medtronic, Northridge, California, USA., Roy A; Medtronic, Northridge, California, USA., Vella M; Medtronic, Northridge, California, USA., Jonkers RAM; Medtronic, Northridge, California, USA., Chen X; Medtronic, Northridge, California, USA., Shin J; Medtronic, Northridge, California, USA., Cordero TL; Medtronic, Northridge, California, USA., Lee SW; Medtronic, Northridge, California, USA., Rhinehart AS; Medtronic, Northridge, California, USA., Vigersky RA; Medtronic, Northridge, California, USA. |
| Source: | Diabetes technology & therapeutics [Diabetes Technol Ther] 2022 Mar; Vol. 24 (3), pp. 178-189. Date of Electronic Publication: 2021 Nov 16. |
| Publication Type: | Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 100889084 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-8593 (Electronic) Linking ISSN: 15209156 NLM ISO Abbreviation: Diabetes Technol Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 34694909 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Safety and Glycemic Outcomes During the MiniMed™ Advanced Hybrid Closed-Loop System Pivotal Trial in Adolescents and Adults with Type 1 Diabetes. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Carlson+AL%22">Carlson AL</searchLink>; International Diabetes Center, HealthPartners Institute, Minneapolis, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Sherr+JL%22">Sherr JL</searchLink>; Yale University School of Medicine Pediatric Endocrinology, New Haven, Connecticut, USA.<br /><searchLink fieldCode="AU" term="%22Shulman+DI%22">Shulman DI</searchLink>; University of South Florida Diabetes and Endocrinology, Tampa, Florida, USA.<br /><searchLink fieldCode="AU" term="%22Garg+SK%22">Garg SK</searchLink>; Barbara Davis Center of Childhood Diabetes, Aurora, Colorado, USA.<br /><searchLink fieldCode="AU" term="%22Pop-Busui+R%22">Pop-Busui R</searchLink>; Division of Metabolism, Endocrinology and Diabetes, University of Michigan, Ann Arbor, Michigan, USA.<br /><searchLink fieldCode="AU" term="%22Bode+BW%22">Bode BW</searchLink>; Atlanta Diabetes Associates, Atlanta, Georgia, USA.<br /><searchLink fieldCode="AU" term="%22Lilenquist+DR%22">Lilenquist DR</searchLink>; Rocky Mountain Diabetes and Osteoporosis Center, Idaho Falls, Idaho, USA.<br /><searchLink fieldCode="AU" term="%22Brazg+RL%22">Brazg RL</searchLink>; Rainier Clinical Research Center, Renton, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Kaiserman+KB%22">Kaiserman KB</searchLink>; SoCal Diabetes, Torrance, California, USA.<br /><searchLink fieldCode="AU" term="%22Kipnes+MS%22">Kipnes MS</searchLink>; Diabetes and Glandular Disease Clinic, San Antonio, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Thrasher+JR%22">Thrasher JR</searchLink>; Arkansas Diabetes and Endocrinology Center, Little Rock, Arkansas, USA.<br /><searchLink fieldCode="AU" term="%22Reed+JHC%22">Reed JHC</searchLink>; Endocrine Research Solutions, Inc., Roswell, Georgia, USA.<br /><searchLink fieldCode="AU" term="%22Slover+RH%22">Slover RH</searchLink>; Barbara Davis Center of Childhood Diabetes, Aurora, Colorado, USA.<br /><searchLink fieldCode="AU" term="%22Philis-Tsimikas+A%22">Philis-Tsimikas A</searchLink>; Scripps Whittier Diabetes Institute, La Jolla, California, USA.<br /><searchLink fieldCode="AU" term="%22Christiansen+M%22">Christiansen M</searchLink>; Diablo Clinical Research Center, Walnut Creek, California, USA.<br /><searchLink fieldCode="AU" term="%22Grosman+B%22">Grosman B</searchLink>; Medtronic, Northridge, California, USA.<br /><searchLink fieldCode="AU" term="%22Roy+A%22">Roy A</searchLink>; Medtronic, Northridge, California, USA.<br /><searchLink fieldCode="AU" term="%22Vella+M%22">Vella M</searchLink>; Medtronic, Northridge, California, USA.<br /><searchLink fieldCode="AU" term="%22Jonkers+RAM%22">Jonkers RAM</searchLink>; Medtronic, Northridge, California, USA.<br /><searchLink fieldCode="AU" term="%22Chen+X%22">Chen X</searchLink>; Medtronic, Northridge, California, USA.<br /><searchLink fieldCode="AU" term="%22Shin+J%22">Shin J</searchLink>; Medtronic, Northridge, California, USA.<br /><searchLink fieldCode="AU" term="%22Cordero+TL%22">Cordero TL</searchLink>; Medtronic, Northridge, California, USA.<br /><searchLink fieldCode="AU" term="%22Lee+SW%22">Lee SW</searchLink>; Medtronic, Northridge, California, USA.<br /><searchLink fieldCode="AU" term="%22Rhinehart+AS%22">Rhinehart AS</searchLink>; Medtronic, Northridge, California, USA.<br /><searchLink fieldCode="AU" term="%22Vigersky+RA%22">Vigersky RA</searchLink>; Medtronic, Northridge, California, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22100889084%22">Diabetes technology & therapeutics</searchLink> [Diabetes Technol Ther] 2022 Mar; Vol. 24 (3), pp. 178-189. <i>Date of Electronic Publication: </i>2021 Nov 16. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Mary+Ann+Liebert%2C+Inc%22">Mary Ann Liebert, Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>100889084 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1557-8593 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215209156%22">15209156 </searchLink><i>NLM ISO Abbreviation: </i>Diabetes Technol Ther <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34694909 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1089/dia.2021.0319 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 178 Titles: – TitleFull: Safety and Glycemic Outcomes During the MiniMed™ Advanced Hybrid Closed-Loop System Pivotal Trial in Adolescents and Adults with Type 1 Diabetes. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Carlson AL – PersonEntity: Name: NameFull: Sherr JL – PersonEntity: Name: NameFull: Shulman DI – PersonEntity: Name: NameFull: Garg SK – PersonEntity: Name: NameFull: Pop-Busui R – PersonEntity: Name: NameFull: Bode BW – PersonEntity: Name: NameFull: Lilenquist DR – PersonEntity: Name: NameFull: Brazg RL – PersonEntity: Name: NameFull: Kaiserman KB – PersonEntity: Name: NameFull: Kipnes MS – PersonEntity: Name: NameFull: Thrasher JR – PersonEntity: Name: NameFull: Reed JHC – PersonEntity: Name: NameFull: Slover RH – PersonEntity: Name: NameFull: Philis-Tsimikas A – PersonEntity: Name: NameFull: Christiansen M – PersonEntity: Name: NameFull: Grosman B – PersonEntity: Name: NameFull: Roy A – PersonEntity: Name: NameFull: Vella M – PersonEntity: Name: NameFull: Jonkers RAM – PersonEntity: Name: NameFull: Chen X – PersonEntity: Name: NameFull: Shin J – PersonEntity: Name: NameFull: Cordero TL – PersonEntity: Name: NameFull: Lee SW – PersonEntity: Name: NameFull: Rhinehart AS – PersonEntity: Name: NameFull: Vigersky RA IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 03 Text: 2022 Mar Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 1557-8593 Numbering: – Type: volume Value: 24 – Type: issue Value: 3 Titles: – TitleFull: Diabetes technology & therapeutics Type: main |
| ResultId | 1 |